Polymorphonuclear granulocytes enhance lipopolysaccharide‐induced soluble p75 tumor necrosis factor receptor release from mononuclear cells
- 1 September 1995
- journal article
- research article
- Published by Wiley in European Journal of Immunology
- Vol. 25 (9), 2714-2717
- https://doi.org/10.1002/eji.1830250948
Abstract
Lipopolysaccharide (LPS), a part of the Gram‐negative bacteria cell wall, is a potent inducer of tumor necrosis factor (TNF). TNF is an important mediator in Gram‐negative infections such as meningococcal septic shock, but its harmful action can be prevented by the natural occurring soluble (s) TNF receptors (sTNFR) sp55 and sp75. In this study, the effect of LPS on release of sTNFR was investigated. First, we found a selective increase in human whole‐blood sp75 TNFR levels following LPS stimulation, accompanied by no increase in sp55. Separating the different blood cell populations, mononuclear cells (PBMC) selectively released sp75 upon LPS stimulation, while LPS induced a minor increase in sp75 release from polymorphonuclear granulocytes. Interestingly, in co‐cultures of PBMC and granulocytes, the release of LPS‐induced sp75 TNFR was enhanced. Second, adherent monocytes were also found to selectively release sp75 TNFR upon LPS stimulation, where Neisseria meningitidis LPS was found to be 100‐1000 times more potent in inducing sp75 release than Escherichia coli LPS. Using flow cytometry, the monocyte membrane distribution of both TNFR were found to be increased after LPS stimulation. Third, human umbilical vein endothelial cells selectively released sp55 TNFR after stimulation with LPS. We conclude that mononuclear and endothelial cells might be the main sources of soluble p75 and p55 TNFR, respectively, observed in Gramnegative sepsis, although these receptors are released in vivo more rapidly than they are in vitro.Keywords
This publication has 26 references indexed in Scilit:
- Tumor necrosis factor alpha (TNF-alpha)-induced cell adhesion to human endothelial cells is under dominant control of one TNF receptor type, TNF-R55.The Journal of Experimental Medicine, 1993
- Release of soluble receptors for tumor necrosis factor (TNF) in relation to circulating TNF during experimental endotoxinemia.Journal of Clinical Investigation, 1992
- Meningococcal endotoxin in lethal septic shock plasma studied by gas chromatography, mass-spectrometry, ultracentrifugation, and electron microscopy.Journal of Clinical Investigation, 1992
- Recombinant soluble tumor necrosis factor receptor proteins protect mice from lipopolysaccharide‐induced lethalityEuropean Journal of Immunology, 1991
- Characterization of binding and biological effects of monoclonal antibodies against a human tumor necrosis factor receptor.The Journal of Experimental Medicine, 1990
- Cytokine regulation of interleukin 6 production by human endothelial cellsCellular Immunology, 1989
- The Biology of Cachectin/TNF -- A Primary Mediator of the Host ResponseAnnual Review of Immunology, 1989
- ASSOCIATION BETWEEN TUMOUR NECROSIS FACTOR IN SERUM AND FATAL OUTCOME IN PATIENTS WITH MENINGOCOCCAL DISEASEThe Lancet, 1987
- Shock and Tissue Injury Induced by Recombinant Human CachectinScience, 1986
- Culture of Human Endothelial Cells Derived from Umbilical Veins. IDENTIFICATION BY MORPHOLOGIC AND IMMUNOLOGIC CRITERIAJournal of Clinical Investigation, 1973